FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:ATAD2-KHDRBS3

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: ATAD2-KHDRBS3
FusionPDB ID: 7352
FusionGDB2.0 ID: 7352
HgeneTgene
Gene symbol

ATAD2

KHDRBS3

Gene ID

29028

10656

Gene nameATPase family AAA domain containing 2KH RNA binding domain containing, signal transduction associated 3
SynonymsANCCA|CT137|PRO2000Etle|SALP|SLM-2|SLM2|T-STAR|TSTAR|etoile
Cytomap

8q24.13

8q24.23

Type of geneprotein-codingprotein-coding
DescriptionATPase family AAA domain-containing protein 2AAA nuclear coregulator cancer-associated proteinKH domain-containing, RNA-binding, signal transduction-associated protein 3KH domain containing, RNA binding, signal transduction associated 3RNA-binding protein T-StarSam68-like phosphotyrosine protein, T-STARsam68-like mammalian protein 2
Modification date2020032220200313
UniProtAcc

Q9ULI0

Main function of 5'-partner protein:

O75525

Main function of 5'-partner protein: FUNCTION: RNA-binding protein that plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. Binds preferentially to the 5'-[AU]UAAA-3' motif in vitro. Binds optimally to RNA containing 5'-[AU]UAA-3' as a bipartite motif spaced by more than 15 nucleotides. Binds poly(A). RNA-binding abilities are down-regulated by tyrosine kinase PTK6 (PubMed:10564820, PubMed:19561594, PubMed:26758068). Involved in splice site selection of vascular endothelial growth factor (PubMed:15901763). In vitro regulates CD44 alternative splicing by direct binding to purine-rich exonic enhancer (By similarity). Can regulate alternative splicing of neurexins NRXN1-3 in the laminin G-like domain 6 containing the evolutionary conserved neurexin alternative spliced segment 4 (AS4) involved in neurexin selective targeting to postsynaptic partners such as neuroligins and LRRTM family members (PubMed:26758068). Targeted, cell-type specific splicing regulation of NRXN1 at AS4 is involved in neuronal glutamatergic synapse function and plasticity (By similarity). May regulate expression of KHDRBS2/SLIM-1 in defined brain neuron populations by modifying its alternative splicing (By similarity). Can bind FABP9 mRNA (By similarity). May play a role as a negative regulator of cell growth. Inhibits cell proliferation. {ECO:0000250|UniProtKB:Q9JLP1, ECO:0000250|UniProtKB:Q9R226, ECO:0000269|PubMed:10564820, ECO:0000269|PubMed:15901763, ECO:0000269|PubMed:19561594, ECO:0000269|PubMed:26758068}.; FUNCTION: (Microbial infection) Involved in post-transcriptional regulation of HIV-1 gene expression. {ECO:0000269|PubMed:11741900}.
Ensembl transtripts involved in fusion geneENST idsENST00000287394, ENST00000521903, 
ENST00000534257, 
ENST00000522578, 
ENST00000355849, ENST00000520981, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score18 X 16 X 9=259211 X 10 X 10=1100
# samples 2214
** MAII scorelog2(22/2592*10)=-3.55849028935997
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(14/1100*10)=-2.97400479146706
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: ATAD2 [Title/Abstract] AND KHDRBS3 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: ATAD2 [Title/Abstract] AND KHDRBS3 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)ATAD2(124346118)-KHDRBS3(136533480), # samples:3
Anticipated loss of major functional domain due to fusion event.ATAD2-KHDRBS3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ATAD2-KHDRBS3 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
ATAD2-KHDRBS3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ATAD2-KHDRBS3 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
ATAD2-KHDRBS3 seems lost the major protein functional domain in Hgene partner, which is a epigenetic factor due to the frame-shifted ORF.
ATAD2-KHDRBS3 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
ATAD2-KHDRBS3 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneATAD2

GO:0045893

positive regulation of transcription, DNA-templated

17998543



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:124346118/chr8:136533480)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across ATAD2 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across KHDRBS3 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000287394ATAD2chr8124346118-ENST00000355849KHDRBS3chr8136533480+5065358610845381476
ENST00000287394ATAD2chr8124346118-ENST00000520981KHDRBS3chr8136533480+4465358610839381276

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000287394ENST00000355849ATAD2chr8124346118-KHDRBS3chr8136533480+0.0004511680.99954885
ENST00000287394ENST00000520981ATAD2chr8124346118-KHDRBS3chr8136533480+0.0004622020.9995378

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for ATAD2-KHDRBS3

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
ATAD2chr8124346118KHDRBS3chr813653348035861159LKTPSTPVACSTPEIEKFQKGEGKDE

Top

Potential FusionNeoAntigen Information of ATAD2-KHDRBS3 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ATAD2-KHDRBS3_124346118_136533480.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:01CSTPEIEKF0.98540.9347918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B58:01CSTPEIEKF0.98370.7734918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B15:16CSTPEIEKF0.97990.6263918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B58:02CSTPEIEKF0.97210.9027918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:03CSTPEIEKF0.96790.9438918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B58:02ACSTPEIEKF0.99580.9287818
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:03ACSTPEIEKF0.98590.9776818
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B58:01ACSTPEIEKF0.97420.8788818
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B58:02VACSTPEIEKF0.99990.9398718
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:03VACSTPEIEKF0.99980.9798718
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B58:01VACSTPEIEKF0.99910.8976718
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:04CSTPEIEKF0.98790.6631918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:10CSTPEIEKF0.98540.9347918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B58:06CSTPEIEKF0.97620.7217918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:02CSTPEIEKF0.93850.8171918
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:04ACSTPEIEKF0.99820.7505818
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:02ACSTPEIEKF0.99170.9001818
ATAD2-KHDRBS3chr8124346118chr81365334803586HLA-B57:02VACSTPEIEKF0.99980.8898718

Top

Potential FusionNeoAntigen Information of ATAD2-KHDRBS3 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
ATAD2-KHDRBS3_124346118_136533480.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0802TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0804TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0804STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0804CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0806TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0806STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0806CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0808TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0809TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0810TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0810STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0811TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0812TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0812STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0813TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0820TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0820STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0820CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0821TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0822TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0822STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0822CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0824TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0828TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0828STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0828CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0831TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0831STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-0831CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1101TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1102TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1102STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1103TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1103STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1103CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1104TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1104STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1104CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1105TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1105STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1106TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1106STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1109TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1110TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1111TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1111STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1112TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1113TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1113STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1115TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1116TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1116STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1118TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1118STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1118CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1121TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1121STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1124TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1125TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1125STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1125CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1128TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1129TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1132TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1132STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1133TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1134TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1134STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1135TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1135STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1135CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1136TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1136STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1138TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1138STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1138CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1139TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1141TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1141STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1141CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1142TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1142STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1142CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1143TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1143STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1143CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1144TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1144STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1144CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1146TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1146STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1146CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1147TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1147STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1148TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1148STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1149TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1150TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1150STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1151TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1154TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1154STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1155TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1155STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1156TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1156STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1157TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1157STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1158TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1158STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1158CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1159TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1159STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1159CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1160TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1160STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1160CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1161TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1162TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1163TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1163STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1163CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1165TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1165STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1166TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1167TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1167STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1167CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1169TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1169STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1170TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1170STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1174TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1175TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1176TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1176STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1176CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1177TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1177STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1177CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1178TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1178STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1178CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1180TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1182TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1183TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1183STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1184TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1184STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1185TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1185STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1185CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1187TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1188TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1188STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1189TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1190TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1191TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1192TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1192STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1194TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1195TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1196TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1204TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1209TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1301TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1301STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1304TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1304STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1304CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1305TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1306TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1306STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1306CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1308TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1308STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1309TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1309STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1309CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1311TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1311STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1311CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1314TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1315TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1315STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1317TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1317STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1317CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1318TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1318STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1318CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1319TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1319STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1320TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1320STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1322TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1322STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1324TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1324STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1324CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1327TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1327STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1332TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1332STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1335TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1335STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1342TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1342STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1342CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1343TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1343STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1344TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1344STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1348TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1348STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1350TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1351TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1351STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1352TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1352STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1353TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1353STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1354TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1354STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1354CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1357TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1357STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1359TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1359STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1362TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1363TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1363STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1364TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1364STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1368TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1368STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1369TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1369STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1370TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1370STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1371TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1371STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1372TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1372STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1375TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1375STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1375CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1376TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1378TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1378STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1379TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1379STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1380TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1380STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1383TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1383STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1384TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1384STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1387TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1387STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1391TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1391STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1392TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1392STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1393TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1393STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1393CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1398TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1398STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1406TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1406STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1412TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1412STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1412CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1415TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1415STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1415CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1416TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1416STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1417TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1417STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1420TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1420STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1421TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1427TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1429TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1434TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1437TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1437STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1437CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1452TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1452STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1453TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1473TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1473STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1474TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1474STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1478TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1478STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1478CSTPEIEKFQKGEGK924
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1480TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1480STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1481TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1483TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1483STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1484TPEIEKFQKGEGKDE1126
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1484STPEIEKFQKGEGKD1025
ATAD2-KHDRBS3chr8124346118chr81365334803586DRB1-1484CSTPEIEKFQKGEGK924

Top

Fusion breakpoint peptide structures of ATAD2-KHDRBS3

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7065PVACSTPEIEKFQKATAD2KHDRBS3chr8124346118chr81365334803586

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of ATAD2-KHDRBS3

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN7065PVACSTPEIEKFQK-7.15543-7.26883
HLA-B14:023BVN7065PVACSTPEIEKFQK-4.77435-5.80965
HLA-B52:013W397065PVACSTPEIEKFQK-6.80875-6.92215
HLA-B52:013W397065PVACSTPEIEKFQK-4.20386-5.23916
HLA-A11:014UQ27065PVACSTPEIEKFQK-7.5194-8.5547
HLA-A11:014UQ27065PVACSTPEIEKFQK-6.9601-7.0735
HLA-A24:025HGA7065PVACSTPEIEKFQK-7.52403-7.63743
HLA-A24:025HGA7065PVACSTPEIEKFQK-5.82433-6.85963
HLA-B27:056PYJ7065PVACSTPEIEKFQK-3.28285-4.31815
HLA-B44:053DX87065PVACSTPEIEKFQK-5.91172-6.94702
HLA-B44:053DX87065PVACSTPEIEKFQK-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of ATAD2-KHDRBS3

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
ATAD2-KHDRBS3chr8124346118chr8136533480718VACSTPEIEKFTGGCTTGCAGCACTCCTGAAATAGAAAAGTTTC
ATAD2-KHDRBS3chr8124346118chr8136533480818ACSTPEIEKFCTTGCAGCACTCCTGAAATAGAAAAGTTTC
ATAD2-KHDRBS3chr8124346118chr8136533480918CSTPEIEKFGCAGCACTCCTGAAATAGAAAAGTTTC

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
ATAD2-KHDRBS3chr8124346118chr81365334801025STPEIEKFQKGEGKDGCACTCCTGAAATAGAAAAGTTTCAAAAAGGAGAAGGCAAGGATG
ATAD2-KHDRBS3chr8124346118chr81365334801126TPEIEKFQKGEGKDECTCCTGAAATAGAAAAGTTTCAAAAAGGAGAAGGCAAGGATGAAG
ATAD2-KHDRBS3chr8124346118chr8136533480924CSTPEIEKFQKGEGKGCAGCACTCCTGAAATAGAAAAGTTTCAAAAAGGAGAAGGCAAGG

Top

Information of the samples that have these potential fusion neoantigens of ATAD2-KHDRBS3

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCECATAD2-KHDRBS3chr8124346118ENST00000287394chr8136533480ENST00000355849TCGA-DF-A2KR-01A

Top

Potential target of CAR-T therapy development for ATAD2-KHDRBS3

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to ATAD2-KHDRBS3

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to ATAD2-KHDRBS3

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource